ICICI Direct: Advanced Enzyme  - A Play On Biotechnology With Enzymes Expertise
A technician at a drug facility. (Photographer: Namas Bhojani/Bloomberg)

ICICI Direct: Advanced Enzyme - A Play On Biotechnology With Enzymes Expertise


BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Direct Report

Incorporated by second generation enzymologists, the Rathi brothers in 1989, Advanced Enzyme Technologies Ltd. is one of the largest Indian enzyme companies with a product basket of 400 plus proprietary products developed from 68 indigenous enzymes, probiotics.

It offers these products to 700 plus customers across 45 countries worldwide.

The company develops enzymes mainly through microbial sources, using environment-friendly biotechnology processes.

Click on the attachment to read the full report:

ICICI Direct Advanced Enzymes Initiating Coverage.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.